| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,110 |
968 |
$51K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
971 |
783 |
$42K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
352 |
327 |
$24K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
885 |
819 |
$22K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,549 |
707 |
$14K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
140 |
108 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
636 |
544 |
$5K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
278 |
202 |
$4K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
99 |
92 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
136 |
81 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
56 |
41 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
22 |
13 |
$48.50 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
14 |
12 |
$3.68 |
| 81003 |
|
20 |
12 |
$1.82 |
| 99072 |
|
830 |
541 |
$0.00 |
| 99000 |
|
78 |
67 |
$0.00 |